Dual-template molecular imprinting enables fully synthetic phosphatidylserine-targeted cancer therapy

Authors:

Abstract
This study develops a phosphatidylserine-targeting nanocarrier that enables precise drug delivery to triple-negative breast tumors, significantly inhibiting growth while minimizing systemic toxicity.
Funding Information
  • National Natural Science Foundation of China (22374056)
  • Department of Science and Technology of Jilin Province (20260205025GH)

This publication has 36 references indexed in Scilit: